100 related articles for article (PubMed ID: 23943800)
1. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.
Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ
Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane.
Maira SM; Galetic I; Brazil DP; Kaech S; Ingley E; Thelen M; Hemmings BA
Science; 2001 Oct; 294(5541):374-80. PubMed ID: 11598301
[TBL] [Abstract][Full Text] [Related]
4. CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.
Chen YC; Li HY; Liang JL; Ger LP; Chang HT; Hsiao M; Calkins MJ; Cheng HC; Chuang JH; Lu PJ
Oncotarget; 2017 May; 8(18):29699-29710. PubMed ID: 27447863
[TBL] [Abstract][Full Text] [Related]
5. New players in high fat diet-induced obesity: LETM1 and CTMP.
Park J; Li Y; Kim SH; Yang KJ; Kong G; Shrestha R; Tran Q; Park KA; Jeon J; Hur GM; Lee CH; Kim DH; Park J
Metabolism; 2014 Mar; 63(3):318-27. PubMed ID: 24333006
[TBL] [Abstract][Full Text] [Related]
6. Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways.
Ono H; Sakoda H; Fujishiro M; Anai M; Kushiyama A; Fukushima Y; Katagiri H; Ogihara T; Oka Y; Kamata H; Horike N; Uchijima Y; Kurihara H; Asano T
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1576-85. PubMed ID: 17615157
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.
Shin JY; Chung YS; Kang B; Jiang HL; Yu DY; Han K; Chae C; Moon JH; Jang G; Cho MH
Cancer Gene Ther; 2013 Mar; 20(3):186-94. PubMed ID: 23392203
[TBL] [Abstract][Full Text] [Related]
8. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
9. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
[TBL] [Abstract][Full Text] [Related]
12. Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells.
Hwang SK; Minai-Tehrani A; Yu KN; Chang SH; Kim JE; Lee KH; Park J; Beck GR; Cho MH
Int J Oncol; 2012 May; 40(5):1515-24. PubMed ID: 22200884
[TBL] [Abstract][Full Text] [Related]
13. Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
Simon PO; McDunn JE; Kashiwagi H; Chang K; Goedegebuure PS; Hotchkiss RS; Hawkins WG
Int J Cancer; 2009 Aug; 125(4):942-51. PubMed ID: 19405118
[TBL] [Abstract][Full Text] [Related]
14. Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis.
Parcellier A; Tintignac LA; Zhuravleva E; Cron P; Schenk S; Bozulic L; Hemmings BA
Cell Signal; 2009 Apr; 21(4):639-50. PubMed ID: 19168129
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
Yu J; Henske EP
Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice.
Hwang SK; Kwon JT; Park SJ; Chang SH; Lee ES; Chung YS; Beck GR; Lee KH; Piao L; Park J; Cho MH
Gene Ther; 2007 Dec; 14(24):1721-30. PubMed ID: 17960162
[TBL] [Abstract][Full Text] [Related]
17. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis.
Wang J; Fry CME; Walker CL
Sci Rep; 2019 Mar; 9(1):3920. PubMed ID: 30850672
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
Knobbe CB; Reifenberger J; Blaschke B; Reifenberger G
J Natl Cancer Inst; 2004 Mar; 96(6):483-6. PubMed ID: 15026474
[TBL] [Abstract][Full Text] [Related]
19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
